These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 15690658)

  • 1. HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature.
    Annese V; Piepoli A; Latiano A; Lombardi G; Napolitano G; Caruso N; Cocchiara E; Accadia L; Perri F; Andriulli A
    Dis Colon Rectum; 2005 Jan; 48(1):57-64; discussion 64-5. PubMed ID: 15690658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel disease: susceptibility and disease heterogeneity revealed by human leukocyte antigen genotyping.
    Bouzid D; Kammoun A; Amouri A; Mahfoudh N; Haddouk S; Tahri N; Makni H; Masmoudi H
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):482-7. PubMed ID: 22224635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).
    Bouma G; Oudkerk Pool M; Crusius JB; Schreuder GM; Hellemans HP; Meijer BU; Kostense PJ; Giphart MJ; Meuwissen SG; Peña AS
    Clin Exp Immunol; 1997 Jul; 109(1):175-9. PubMed ID: 9218841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany.
    Reinshagen M; Loeliger C; Kuehnl P; Weiss U; Manfras BJ; Adler G; Boehm BO
    Gut; 1996 Apr; 38(4):538-42. PubMed ID: 8707084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
    Cleynen I; Boucher G; Jostins L; Schumm LP; Zeissig S; Ahmad T; Andersen V; Andrews JM; Annese V; Brand S; Brant SR; Cho JH; Daly MJ; Dubinsky M; Duerr RH; Ferguson LR; Franke A; Gearry RB; Goyette P; Hakonarson H; Halfvarson J; Hov JR; Huang H; Kennedy NA; Kupcinskas L; Lawrance IC; Lee JC; Satsangi J; Schreiber S; Théâtre E; van der Meulen-de Jong AE; Weersma RK; Wilson DC; ; Parkes M; Vermeire S; Rioux JD; Mansfield J; Silverberg MS; Radford-Smith G; McGovern DP; Barrett JC; Lees CW
    Lancet; 2016 Jan; 387(10014):156-67. PubMed ID: 26490195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease.
    Silverberg MS; Mirea L; Bull SB; Murphy JE; Steinhart AH; Greenberg GR; McLeod RS; Cohen Z; Wade JA; Siminovitch KA
    Inflamm Bowel Dis; 2003 Jan; 9(1):1-9. PubMed ID: 12656131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
    Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
    Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
    World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.
    Forcione DG; Sands B; Isselbacher KJ; Rustgi A; Podolsky DK; Pillai S
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5094-8. PubMed ID: 8643533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
    Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
    Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA class II alleles in Japanese patients with inflammatory bowel disease.
    Yoshitake S; Kimura A; Okada M; Yao T; Sasazuki T
    Tissue Antigens; 1999 Apr; 53(4 Pt 1):350-8. PubMed ID: 10323339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.
    Kim BG; Kim YS; Kim JS; Jung HC; Song IS
    Dis Colon Rectum; 2002 Aug; 45(8):1062-9. PubMed ID: 12195191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hla-B genotype in Japanese patients with Crohn's disease.
    Kinouchi Y; Matsumoto K; Negoro K; Takagi S; Takahashi S; Hiwatashi N; Shimosegawa T
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S10-4. PubMed ID: 14530653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an assay for antibodies to Saccharomyces cerevisiae: Easy, cheap and specific for Crohn's disease.
    Bernstein CN; Orr K; Blanchard JF; Sargent M; Workman D
    Can J Gastroenterol; 2001 Aug; 15(8):499-504. PubMed ID: 11544532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.
    Stokkers PC; Reitsma PH; Tytgat GN; van Deventer SJ
    Gut; 1999 Sep; 45(3):395-401. PubMed ID: 10446108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
    Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.